NS
InspireMD, Inc.
NSPR · NASDAQ
$0.76 +1.16% (+$0.01)
1M -13.78%
Market Cap $34.8M
P/E Ratio -
Div. Yield -
ROE 79.21%
Piotroski F-Score Weak
2/9Valuation
78 /100
Cheap P/B 1.10x
P/S 3.21x
PEG N/A
Growth
100 /100
Growing Book val. growth 46.96%
Rev. growth 20.19%
FCF growth N/A
Profitability
5 /100
Weak FCF margin 391.67%
Op. margin 494.03%
Gross margin 18.05%
Quality
3 /100
Poor Asset turnover 0.24x
ROA 86.25%
ROIC 153.30%
Debt
100 /100
Low Current ratio 3.80x
Debt/Equity 0.06x
Net debt/EBITDA N/A
Stability
73 /100
Stable Profitable years 0
EPS volatility 35.67%
Beta 0.82x
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o NSPR
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Marvin L. Slosman
Employees
127
Headquarters
Miami
Nadchodzące wydarzenia
10 LIS
Earnings
Upcoming earnings report